OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) was the target of a large increase in short interest in August. As of August 15th, there was short interest totalling 1,250,000 shares, an increase of 6.8% from the July 31st total of 1,170,000 shares. Based on an average daily trading volume, of 85,500 shares, the short-interest ratio is presently 14.6 days. Approximately 8.0% of the shares of the stock are short sold.
Analyst Ratings Changes
KIDS has been the subject of a number of recent analyst reports. Needham & Company LLC reiterated a “buy” rating and set a $55.00 price target on shares of OrthoPediatrics in a report on Tuesday, August 1st. Truist Financial lowered their price target on shares of OrthoPediatrics from $57.00 to $51.00 and set a “buy” rating for the company in a report on Wednesday, August 2nd. Finally, JMP Securities reiterated a “market outperform” rating and set a $60.00 price target on shares of OrthoPediatrics in a report on Tuesday, August 1st. Four investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, OrthoPediatrics presently has an average rating of “Buy” and a consensus target price of $53.60.
Insiders Place Their Bets
Institutional Trading of OrthoPediatrics
A number of hedge funds and other institutional investors have recently modified their holdings of KIDS. Point72 Hong Kong Ltd purchased a new stake in shares of OrthoPediatrics in the 1st quarter worth about $26,000. Almanack Investment Partners LLC. purchased a new stake in shares of OrthoPediatrics in the 3rd quarter worth about $34,000. FMR LLC grew its position in shares of OrthoPediatrics by 71.7% in the 1st quarter. FMR LLC now owns 874 shares of the company’s stock worth $39,000 after buying an additional 365 shares during the period. State of Wyoming grew its position in OrthoPediatrics by 23.1% during the 4th quarter. State of Wyoming now owns 1,380 shares of the company’s stock valued at $55,000 after purchasing an additional 259 shares during the last quarter. Finally, Lazard Asset Management LLC purchased a new stake in OrthoPediatrics during the 1st quarter valued at about $65,000. 68.36% of the stock is owned by hedge funds and other institutional investors.
OrthoPediatrics Trading Down 1.1 %
Shares of NASDAQ KIDS opened at $38.22 on Friday. OrthoPediatrics has a 12 month low of $35.63 and a 12 month high of $53.50. The firm has a market capitalization of $892.44 million, a PE ratio of 424.67 and a beta of 0.87. The firm has a fifty day simple moving average of $41.02 and a two-hundred day simple moving average of $43.70.
OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last released its earnings results on Monday, July 31st. The company reported ($0.19) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.19). The firm had revenue of $39.56 million for the quarter, compared to the consensus estimate of $39.11 million. OrthoPediatrics had a net margin of 0.73% and a negative return on equity of 5.03%. On average, sell-side analysts predict that OrthoPediatrics will post -0.97 earnings per share for the current year.
OrthoPediatrics Company Profile
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
- Five stocks we like better than OrthoPediatrics
- P/E Ratio Calculation: How to Assess Stocks
- 3 Takeaways from the August Inflation Report
- What Are Trending Stocks? Trending Stocks Explained
- On Fire: 5 Best Artificial Intelligence Penny Stocks
- Breakout Stocks: What They Are and How to Identify Them
- 6 Cybersecurity Stocks: Which is the Best to Buy?
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.